Find a ROS1 Physician
ROS1+ cancer is not a common cancer, and treatment options are evolving quickly. Many physicians may find they are not familiar with the most current treatment options. If a patient or a physician has questions about the next step in treating ROS1+ cancer, they might want to consult one of the physicians listed here. All have treated ROS1+ cancer patients. In addition, they have :
participated in research on ROS1+ cancer (ROS1 Clinician-Researchers), or
consulted with ROS1 Clinician-Researchers about treating ROS1+ cancer patients (ROS1 Clinicians).
ROS1 Clinician-Researchers have participated in ROS1 research and will have the most current information about ROS1+ cancer treatment options, acquired resistance, and clinical trials. Patients who are seeking to learn the best evidence-based options for treatment of their ROS1+ cancer can arrange for an in-person second opinion with these physicians; we've indicated those who also offer remote second opinions to patients. Physicians who need more information about best practices in treating ROS1+ cancer can contact these physicians by email to arrange for a peer consult.
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, Massachusetts, USA
University Hospital of Cologne,
Center for Integrated Oncology Köln Bonn
Moores Cancer Center at
University of California San Diego
San Diego, CA, USA
ROS1 Clinicians have treated patients who have ROS1+ cancer AND have consulted a ROS1 Clinician-Researcher regarding treatment options for one or more patients.
Know a physician who treats ROS1+ cancer?
Please tell us about them using this survey: